LBA2 DeFi: A phase III, randomized controlled trial of nirogacestat versus placebo for progressing desmoid tumors (DT)
Conference Paper
Full Text
Duke Authors
Cited Authors
- Kasper, B; Ratan, R; Alcindor, T; Schoeffski, P; van der Graaf, WTA; Wilky, BA; Riedel, RF; Lim, A; Smith, LM; Moody, S; Attia, S; Chawla, SP; D'Amato, G; Federman, N; Van Tine, P; Van Tine, BA; Vincenzi, B; Kummar, S; Gounder, MM
Published Date
- September 2022
Published In
Volume / Issue
- 33 /
Start / End Page
- S1435 - S1436
Published By
International Standard Serial Number (ISSN)
- 0923-7534
Digital Object Identifier (DOI)
- 10.1016/j.annonc.2022.08.075